0001144204-11-022278.txt : 20110415
0001144204-11-022278.hdr.sgml : 20110415
20110415105346
ACCESSION NUMBER: 0001144204-11-022278
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20110413
FILED AS OF DATE: 20110415
DATE AS OF CHANGE: 20110415
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Leventhal Mark S
CENTRAL INDEX KEY: 0001459632
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-21617
FILM NUMBER: 11761387
MAIL ADDRESS:
STREET 1: THE BEACON COMPANIES
STREET 2: 50 FEDERAL STREET
CITY: BOSTON
STATE: MA
ZIP: 02468
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ProPhase Labs, Inc.
CENTRAL INDEX KEY: 0000868278
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 232577138
STATE OF INCORPORATION: NV
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 621 N. SHADY RETREAT ROAD
CITY: DOYLESTOWN
STATE: PA
ZIP: 18901
BUSINESS PHONE: 2153450919
MAIL ADDRESS:
STREET 1: 621 N. SHADY RETREAT ROAD
CITY: DOYLESTOWN
STATE: PA
ZIP: 18901
FORMER COMPANY:
FORMER CONFORMED NAME: QUIGLEY CORP
DATE OF NAME CHANGE: 19930328
4
1
v218649_ex.xml
X0303
4
2011-04-13
0
0000868278
ProPhase Labs, Inc.
PRPH
0001459632
Leventhal Mark S
621 N. SHADY RETREAT ROAD
DOYLESTOWN
PA
18901
1
0
0
0
Common Stock, par value $0.0005
2011-04-13
4
A
0
7235
0
A
267990
D
These restricted shares of common stock were issued pursuant to the terms of the 2010 Directors' Equity Compensation Plan for
Board fees payable to non-employee directors. The 2010 Directors' Equity Compensation Plan was approved by the Company's
stockholders on May 5, 2010.
/s/ Mark Leventhal
2011-04-13